Market Cap ₹19 Cr.
Stock P/E
P/B 1.9
Current Price ₹54
Book Value ₹ 28.7
Face Value 10
52W High ₹78.8
Dividend Yield 0%
52W Low ₹ 49.4
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2023 | TTM |
---|---|---|
Net Sales | 6 | |
Other Income | 0 | |
Total Income | 6 | |
Total Expenditure | 5 | |
Operating Profit | 0 | |
Interest | 0 | |
Depreciation | 0 | |
Exceptional Income / Expenses | 0 | |
Profit Before Tax | 0 | |
Provision for Tax | 0 | |
Profit After Tax | 0 | |
Adjustments | 0 | |
Profit After Adjustments | 0 | |
Adjusted Earnings Per Share | 0.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 5% | 5% | 5% | 5% |
ROCE Average | 7% | 7% | 7% | 7% |
#(Fig in Cr.) | Mar 2023 |
---|---|
Shareholder's Funds | 3 |
Minority's Interest | 0 |
Borrowings | 0 |
Other Non-Current Liabilities | 0 |
Total Current Liabilities | 1 |
Total Liabilities | 3 |
Fixed Assets | 0 |
Other Non-Current Assets | 0 |
Total Current Assets | 3 |
Total Assets | 3 |
#(Fig in Cr.) | Mar 2023 |
---|---|
Opening Cash & Cash Equivalents | 0 |
Cash Flow from Operating Activities | -3 |
Cash Flow from Investing Activities | -0 |
Cash Flow from Financing Activities | 3 |
Net Cash Inflow / Outflow | 0 |
Closing Cash & Cash Equivalent | 0 |
# | Mar 2023 |
---|---|
Earnings Per Share (Rs) | 0.52 |
CEPS(Rs) | 0.56 |
DPS(Rs) | 0 |
Book NAV/Share(Rs) | 10.34 |
Core EBITDA Margin(%) | 4 |
EBIT Margin(%) | 3.88 |
Pre Tax Margin(%) | 3.26 |
PAT Margin (%) | 2.41 |
Cash Profit Margin (%) | 2.62 |
ROA(%) | 4.1 |
ROE(%) | 4.98 |
ROCE(%) | 6.72 |
Receivable days | 13.72 |
Inventory Days | 171.22 |
Payable days | 4.13 |
PER(x) | 0 |
Price/Book(x) | 0 |
Dividend Yield(%) | 0 |
EV/Net Sales(x) | 0.16 |
EV/Core EBITDA(x) | 3.92 |
Net Sales Growth(%) | 0 |
EBIT Growth(%) | 0 |
PAT Growth(%) | 0 |
EPS Growth(%) | 0 |
Debt/Equity(x) | 0.19 |
Current Ratio(x) | 5.25 |
Quick Ratio(x) | 0.78 |
Interest Cover(x) | 6.27 |
Total Debt/Mcap(x) | 0 |
# | Mar 2024 |
---|---|
Promoter | 72.07 |
FII | 0 |
DII | 0 |
Public | 27.93 |
Others | 0 |
Total | 100 |
# | Mar 2024 |
---|---|
Promoter | 0.26 |
FII | 0 |
DII | 0 |
Public | 0.1 |
Others | 0 |
Total | 0.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About